Ramsay Health Care Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Ramsay Health Care wird ein jährliches Gewinn- und Umsatzwachstum von 14.5% bzw. 5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 17.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.7% betragen.

Wichtige Informationen

19.6%

Wachstumsrate der Gewinne

19.5%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	25.3%
Wachstumsrate der Einnahmen	4.4%
Zukünftige Eigenkapitalrendite	9.2%
Analystenabdeckung	Good
Zuletzt aktualisiert	26 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Why Investors Shouldn't Be Surprised By Ramsay Health Care Limited's (ASX:RHC) P/E

Sep 18

Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital

Jul 12

Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 54% Above Its Share Price

Jun 24

Shareholders Should Be Pleased With Ramsay Health Care Limited's (ASX:RHC) Price

Jun 06

Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 68% Above Its Share Price

Feb 15

We Think Ramsay Health Care (ASX:RHC) Is Taking Some Risk With Its Debt

Sep 16

Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital

Aug 22

Is There An Opportunity With Ramsay Health Care Limited's (ASX:RHC) 27% Undervaluation?

Jun 22

Does Ramsay Health Care (ASX:RHC) Have A Healthy Balance Sheet?

Jun 07

There Are Reasons To Feel Uneasy About Ramsay Health Care's (ASX:RHC) Returns On Capital

May 09

What Is The Ownership Structure Like For Ramsay Health Care Limited (ASX:RHC)?

Mar 16

Income Investors Should Know That Ramsay Health Care Limited (ASX:RHC) Goes Ex-Dividend Soon

Mar 03

Ramsay Health Care Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 26

Are Insiders Buying Ramsay Health Care Limited (ASX:RHC) Stock?

Feb 15

Gewinn- und Umsatzwachstumsprognosen

ASX:RHC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2027	19,094	502	861	1,656	12
6/30/2026	18,389	402	782	1,584	14
6/30/2025	17,554	313	672	1,505	14
6/30/2024	16,660	254	539	1,293	N/A
3/31/2024	16,094	223	N/A	N/A	N/A
12/31/2023	15,945	221	296	1,046	N/A
9/30/2023	15,561	274	N/A	N/A	N/A
6/30/2023	14,964	265	559	1,280	N/A
3/31/2023	14,418	299	N/A	N/A	N/A
12/31/2022	13,943	272	286	978	N/A
9/30/2022	13,528	264	N/A	N/A	N/A
6/30/2022	13,312	250	7	716	N/A
3/31/2022	13,404	311	N/A	N/A	N/A
12/31/2021	13,008	373	-85	627	N/A
9/30/2021	12,929	387	N/A	N/A	N/A
6/30/2021	12,864	440	852	1,481	N/A
3/31/2021	12,511	341	1,150	1,772	N/A
12/31/2020	12,157	242	1,448	2,064	N/A
9/30/2020	12,159	257	1,224	1,872	N/A
6/30/2020	12,160	273	1,000	1,681	N/A
3/31/2020	12,438	397	683	1,364	N/A
12/31/2019	12,717	521	366	1,048	N/A
9/30/2019	12,135	527	338	976	N/A
6/30/2019	11,553	533	310	903	N/A
3/31/2019	10,726	466	408	964	N/A
12/31/2018	9,899	399	507	1,026	N/A
9/30/2018	9,538	388	514	1,010	N/A
6/30/2018	9,176	376	521	995	N/A
3/31/2018	9,003	422	N/A	947	N/A
12/31/2017	8,831	467	N/A	900	N/A
9/30/2017	8,767	472	N/A	891	N/A
6/30/2017	8,703	476	N/A	882	N/A
3/31/2017	8,766	472	N/A	940	N/A
12/31/2016	8,829	468	N/A	998	N/A
9/30/2016	8,758	453	N/A	952	N/A
6/30/2016	8,686	437	N/A	905	N/A
3/31/2016	8,438	421	N/A	838	N/A
12/31/2015	8,190	406	N/A	771	N/A
9/30/2015	7,773	389	N/A	759	N/A
6/30/2015	7,357	372	N/A	746	N/A
3/31/2015	6,626	348	N/A	692	N/A
12/31/2014	5,895	324	N/A	637	N/A
9/30/2014	5,405	307	N/A	599	N/A
6/30/2014	4,915	290	N/A	561	N/A
3/31/2014	4,690	281	N/A	524	N/A
12/31/2013	4,466	271	N/A	487	N/A
9/30/2013	4,322	261	N/A	469	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: RHCDas prognostizierte Gewinnwachstum (14.5% pro Jahr) liegt über der Sparquote (2.3%).

Ertrag vs. Markt: RHCDie Erträge des Unternehmens (17.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (12.2% pro Jahr).

Hohe Wachstumserträge: RHCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: RHCDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Australian (4.9% pro Jahr).

Hohe Wachstumseinnahmen: RHCDie Einnahmen des Unternehmens (5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: RHCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.7%).

Ramsay Health Care Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 22%

Price target decreased by 7.1% to AU$48.43

Consensus EPS estimates increase by 22%

Consensus EPS estimates increase by 15%

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 14%, revenue upgraded

Recent updates

Why Investors Shouldn't Be Surprised By Ramsay Health Care Limited's (ASX:RHC) P/E

Consensus EPS estimates fall by 22%

Price target decreased by 7.1% to AU$48.43

Final dividend increased to AU$0.40

Ramsay Health Care Limited to Report First Half, 2025 Results on Feb 27, 2025

Now 25% undervalued after recent price drop

Private Equity Reportedly Pursues Ramsay

Consensus EPS estimates increase by 22%

Consensus EPS estimates increase by 15%

Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital

Consensus EPS estimates increase by 11%

Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 54% Above Its Share Price

Shareholders Should Be Pleased With Ramsay Health Care Limited's (ASX:RHC) Price

Here's Why Ramsay Health Care (ASX:RHC) Has A Meaningful Debt Burden

Wesfarmers Reportedly Runs the Ruler over Ramsay Health Care

Consensus EPS estimates fall by 14%, revenue upgraded

Upcoming dividend of AU$0.40 per share

First half dividend reduced to AU$0.40

Ramsay Health Care Limited, Annual General Meeting, Nov 26, 2024

First half 2024 earnings released

New minor risk - Profit margin trend

Ramsay Health Care Announces Appointment of Helen Kurincic as Non-Executive Director, Effective March 1, 2024

Consensus EPS estimates fall by 14%

Consensus EPS estimates increase by 33%

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Ramsay Health Care Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

EQT Reportedly in Hunt for Ramsay Offload

Ramsay Health Care Limited to Report First Half, 2024 Results on Feb 29, 2024

Macquarie, Columbia Asia Reportedly Among Bidders for Ramsay-Sime Darby $1.3 Billion Healthcare JV

Citi Reportedly Launches Cura Sale Process with Bids Due Next Month

Upcoming dividend of AU$0.25 per share at 1.5% yield

Consensus EPS estimates fall by 33%, revenue upgraded

New minor risk - Earnings quality

Price target decreased by 7.8% to AU$59.29

Full year 2023 earnings: Revenues exceed analyst expectations

Consensus EPS estimates fall by 15%

Now 24% undervalued after recent price drop

Now 21% undervalued after recent price drop

Upcoming dividend of AU$0.50 per share at 1.4% yield

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Ramsay Reportedly Still Weighing Options for French Stake

Ramsay Health Care Limited Announces Dividend for the Six Months Period Ending April 19, 2023, Payable on April 20, 2023

Ramsay Reportedly Looks At Hospitals Sell-Off

Ramsay Health Care Limited, Annual General Meeting, Nov 21, 2023

A consortium of financial investors including Health Employees Superannuation Trust Australia and led by KKR & Co. Inc. (NYSE:KKR) cancelled the acquisition of Ramsay Health Care Limited (ASX:RHC).

Price target decreased to AU$71.66

Now 20% undervalued after recent price drop

Consensus EPS estimates fall by 21%

Ramsay Health Care Limited Announces Ordinary Distribution for the Six Months Ended June 30, 2022 Payable on September 29, 2022

Full year 2022 earnings: EPS misses analyst expectations

Healius Reportedly Launches Day Surgery Sale Process

GIC Reportedly Eyes Ramsay Operating Company

Consensus forecasts updated

Price target increased to AU$78.38

Price target increased to AU$75.88

Investor sentiment improved over the past week

Ramsay Health Care Limited Announces Franked Dividend on RHCPA - TRANS PREF 6-BBSW+ 4.85% PERP SUB RED T-10-10 for the Six Months Period Ending October 19, 2022, Payable on October 20, 2022

Ramsay Health Care (ASX:RHC) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$0.48 per share

Ramsay Health Care (ASX:RHC) Has Re-Affirmed Its Dividend Of AU$0.48

First half 2022 earnings: EPS exceeds analyst expectations

Ramsay Health Care Limited Announces Franked Dividend on RHCPA - TRANS PREF 6-BBSW+ 4.85% PERP SUB RED T-10-10 for the Six Months Period Ending April 19, 2022, Payable on April 20, 2022

Ramsay Health Care Limited's (ASX:RHC) Intrinsic Value Is Potentially 68% Above Its Share Price

Full year 2021 earnings released: EPS AU$1.93 (vs AU$1.31 in FY 2020)

We Think Ramsay Health Care (ASX:RHC) Is Taking Some Risk With Its Debt

Upcoming dividend of AU$1.03 per share

Full year 2021 earnings released: EPS AU$1.93 (vs AU$1.31 in FY 2020)

Ramsay Health Care (ASX:RHC) May Have Issues Allocating Its Capital

Is There An Opportunity With Ramsay Health Care Limited's (ASX:RHC) 27% Undervaluation?